Skip header and navigation

Refine By

63 records – page 1 of 7.

[Alcohol consumption and liver enzymes in persons 30-50 years of age. Cross-sectional study from Ebeltoft]

https://arctichealth.org/en/permalink/ahliterature10941
Source
Ugeskr Laeger. 1997 Sep 29;159(40):5945-50
Publication Type
Article
Date
Sep-29-1997
Author
F H Steffensen
H T Sørensen
A. Brock
H. Vilstrup
T. Lauritzen
Author Affiliation
Aarhus Universitet, Sundhedsprojekt Ebeltoft, Institut for Almen Medicin og Center for Epidemiologisk Grundforskning.
Source
Ugeskr Laeger. 1997 Sep 29;159(40):5945-50
Date
Sep-29-1997
Language
Danish
Publication Type
Article
Keywords
Adult
Alanine Transaminase - blood
Alcohol Drinking
Aspartate Aminotransferases - blood
Body mass index
Cross-Sectional Studies
Denmark
English Abstract
Female
Humans
Liver - enzymology
Liver Diseases, Alcoholic - diagnosis - enzymology - etiology
Male
Middle Aged
Research Support, Non-U.S. Gov't
Smoking
Abstract
In a representative population sample of 905 persons we examined the prevalence of raised levels of liver-derived enzymes and its possible association with self-reported alcohol consumption adjusted for smoking and BMI applying logistic regression analyses. A large proportion of 12% (women 8%; men 16%) presented raised liver-derived enzymes. Below 21 units per week (one unit equals 12 grams of alcohol) there was no association with self-reported alcohol consumption. However, the risk of abnormal liver enzymes increased with higher consumption for both sexes; if the intake was above 28 units per week, the odds ratio for raised liver enzymes increased dramatically. Whether this subclinical biochemical liver condition is an early marker of alcohol-related liver damage remains to be seen, but the long-term consequences of the reported alcohol consumption and the frequency of raised liver enzymes require follow-up.
PubMed ID
9381568 View in PubMed
Less detail

[Alcoholic and non-alcoholic cirrhosis. Changes in 1965-1978 mortality related to alcohol consumption. Current morbidity 1976-1978]

https://arctichealth.org/en/permalink/ahliterature12991
Source
Ugeskr Laeger. 1981 Apr 27;143(18):1175-9
Publication Type
Article
Date
Apr-27-1981

[Blood tests in infectious mononucleosis. Assessment of cost through a questionnaire study].

https://arctichealth.org/en/permalink/ahliterature233464
Source
Ugeskr Laeger. 1988 Feb 29;150(9):545-7
Publication Type
Article
Date
Feb-29-1988

[Brucellosis as a tourist disease. Report of 2 cases with liver granuloma].

https://arctichealth.org/en/permalink/ahliterature244325
Source
Ugeskr Laeger. 1981 Jul 13;143(29):1843-4
Publication Type
Article
Date
Jul-13-1981
Source
Ugeskr Laeger. 1992 Oct 12;154(42):2911-2
Publication Type
Article
Date
Oct-12-1992
Author
J H Pedersen
P S Clementsen
S. Høyer
B A Hansen
Author Affiliation
Hepatologisk afdeling A, Rigshospitalet, København.
Source
Ugeskr Laeger. 1992 Oct 12;154(42):2911-2
Date
Oct-12-1992
Language
Danish
Publication Type
Article
Keywords
Aged
Captopril - adverse effects
English Abstract
Female
Hepatitis, Toxic - etiology - pathology
Hepatorenal Syndrome - chemically induced
Humans
Liver - drug effects - pathology
Abstract
Captopril, the competitive inhibitor of angiotensin-converting enzyme, has proved efficient in the treatment of arterial hypertension and heart failure. Its use is generally associated with low incidence of adverse reactions and hepatic injury has not been emphasized as an important adverse reaction in Denmark. However worldwide, several cases of hepatic injury have been reported. We report one case of Captopril-induced hepatic injury. Despite discontinuation of Captopril a hepatorenal syndrome developed and the patient died five weeks after admission. This report emphasizes the need to be aware of the possibility of hepatic injury in patients receiving Captopril.
PubMed ID
1413240 View in PubMed
Less detail

[Causes of death among the clientele of an outpatient clinic for alcoholics]

https://arctichealth.org/en/permalink/ahliterature56261
Source
Ugeskr Laeger. 1973 Dec 3;135(49):2709-11
Publication Type
Article
Date
Dec-3-1973

[Chemoembolization--a possible therapeutic strategy in Denmark?]

https://arctichealth.org/en/permalink/ahliterature18770
Source
Ugeskr Laeger. 2002 Nov 4;164(45):5282
Publication Type
Article
Date
Nov-4-2002

[Chemotherapy in metastasing breast cancer--is it beneficial?]

https://arctichealth.org/en/permalink/ahliterature23501
Source
Ugeskr Laeger. 1994 Oct 31;156(44):6549-50
Publication Type
Article
Date
Oct-31-1994
Author
I M Høgsberg
M M Nielsen
S. Cold
C. Rose
Author Affiliation
Onkologisk Afdeling R, Odense Universitetshospital.
Source
Ugeskr Laeger. 1994 Oct 31;156(44):6549-50
Date
Oct-31-1994
Language
Danish
Publication Type
Article
Keywords
Adult
Bone Neoplasms - drug therapy - secondary
Brain Neoplasms - drug therapy - secondary
Breast Neoplasms - drug therapy - mortality
English Abstract
Female
Humans
Liver Neoplasms - drug therapy - secondary
Lymphatic Metastasis
Middle Aged
Prognosis
Time Factors
Abstract
Carcinoma of the breast is the most common type of cancer among women in Denmark (3,000 new cases a year). About half of the patients will at some time develop metastases. Treatment of extended disease is controversial. Public discussion has focused on whether it is desirable to treat these patients with chemotherapy or not. This case story describes four cases with long term survival (nine, ten, 14, 19 years after début of metastases). This underlines that it is possible within the existing types of treatment to achieve both extended survival and acceptable life quality. The doctor's dilemma is that he does not know whom treatment helps. We conclude that treatment should be offered to all patients. This will be of benefit to the whole group.
Notes
Comment In: Ugeskr Laeger. 1995 Jan 16;157(3):3017846781
PubMed ID
7825256 View in PubMed
Less detail

63 records – page 1 of 7.